CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patientâs EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patientâs EEG data.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļCBLL
āļāļ·āđāļāļāļĢāļīāļĐāļąāļCeribell Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļOct 11, 2024
āļāļĩāļāļĩāđāļChao (Xingjuan)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ281
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļOct 11
āļāļĩāđāļāļĒāļđāđ360 N. Pastoria Avenue
āđāļĄāļ·āļāļSUNNYVALE
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ94085
āđāļāļĢāļĻāļąāļāļāđ18004360826
āđāļ§āđāļāđāļāļāđhttps://ceribell.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļCBLL
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļOct 11, 2024
āļāļĩāļāļĩāđāļChao (Xingjuan)
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Mr. Scott Blumberg
Chief Financial Officer
Mr. Joseph M. Taylor
Independent Director
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Ms. Erica J. Rogers
Director
Brian Johnston
Investor Relations
Joseph Manni
Chief Revenue Officer
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Mr. Scott Blumberg
Chief Financial Officer
Mr. Joseph M. Taylor
Independent Director
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
iShares Neuroscience and Healthcare ETF
Fidelity Fundamental Small-Mid Cap ETF
ProShares Hedge Replication ETF
iShares Russell 2000 Growth ETF
ProShares UltraPro Russell2000
Schwab U.S. Small-Cap ETF
Proshares Ultra Russell 2000
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
iShares Neuroscience and Healthcare ETF
āļŠāļąāļāļŠāđāļ§āļ0.57%
Hypatia Women CEO ETF
āļŠāļąāļāļŠāđāļ§āļ0.5%
Fidelity Fundamental Small-Mid Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.1%
iShares Micro-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.06%
ProShares Hedge Replication ETF
āļŠāļąāļāļŠāđāļ§āļ0.02%
iShares Russell 2000 Growth ETF
āļŠāļąāļāļŠāđāļ§āļ0.02%
ProShares UltraPro Russell2000
āļŠāļąāļāļŠāđāļ§āļ0.01%
iShares Russell 2000 ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
Schwab U.S. Small-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
Proshares Ultra Russell 2000
āļŠāļąāļāļŠāđāļ§āļ0.01%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ